New blood pressure pill put to the test in Real-World UAE study

NCT ID NCT07465666

Not yet recruiting Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to see how well a newer combination blood pressure medication (ARNi) works compared to standard single-drug treatments in everyday medical practice. It will involve 500 adults in the United Arab Emirates who have high blood pressure. Researchers will track changes in participants' blood pressure over 12 weeks to see which treatment approach is more effective at reaching healthy targets.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Conditions

Explore the condition pages connected to this study.

HYPERTENSION